NeuroZen Scam Alerts, Consumer Complaints, and Formula Risks Assessed for Adults Researching Ear Health and Adaptogenic ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q1 2026 Earnings Call Transcript May 12, 2026 Acurx Pharmaceuticals, Inc. misses ...
The Synergistic Amino Acid Strategy: Rather than relying on a single ingredient, the BloodPril formula combines direct precursors (L-Arginine) with indirect, sustained-release precursors (L-Citrulline ...
Objective To explore healthcare professionals’ experiences with medication errors (MEs) in terms of types and factors that contribute to them. Design A mixed-methods study was conducted to explore the ...
Forbes contributors publish independent expert analyses and insights. Kim Elsesser covers issues that impact women in the workplace. New research finds that labeling a woman as “emotional” or telling ...
Trial in progress: A phase 1, first-in-human, open-label, multicenter, dose-escalation and dose-expansion study of ASP3082 in patients with previously treated advanced solid tumors and KRAS G12D ...
TACTIVE-U: Phase 1b/2 umbrella study of ARV-471, a proteolysis targeting chimera (PROTAC) estrogen receptor (ER) degrader, combined with other anticancer treatments in ER+ advanced or metastatic ...
Labelling is an important tool to inform consumers and encourage healthier and more sustainable food choices. Governments and organizations worldwide have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results